UNSPSC 51292905: Desipramine hydrochloride

This classification denotes a tricyclic antidepressant with the molecular formula C18H22N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TG537D343B, chemically known as 10,11-dihydro-5-(3-methylaminopropyl)-5h-dibenz(b,f)azepine but generally known as desipramine, which bears US NIH Compound Identifier 2995. European Medicines Agency schedules Desipramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06995MIG.

UNSPSC 51292905 Desipramine hydrochloride is a Commodity code that nominally refers to a specific tricyclic antidepressant pharmaceutical, but recent state and local solicitations tagged with this code show minimal direct relevance to the code's specific scope. The three most recent opportunities in the block address naloxone and drug deactivation systems, a Texas HHS direct-to-manufacturer prescription program inquiry, and generic multi-source pharmaceuticals and over-the-counter products through a multistate cooperative purchasing vehicle — none of which centers on desipramine hydrochloride or tricyclic antidepressants specifically. The mismatch suggests that state and local procurement offices are either tagging pharmaceutical opportunities broadly under this code despite narrow nominal scope, or the code has been applied inconsistently across jurisdictions.

Activity appears concentrated among health and human services agencies and multistate cooperative purchasing groups. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023) for naloxone and drug deactivation systems through competitive bidding. The Texas Health and Human Services Commission posted an RFI in April 2026 exploring direct-to-manufacturer prescription contracting models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota and Oregon. Without a clear recent solicitation directly targeting desipramine hydrochloride, the code shows little focused activity in its stated pharmaceutical category and warrants verification against issuing bodies' actual intent before pursuing.